Ocular Inflammation as a Risk Factor for Antiadalimumab Antibodies in Patients with Autoimmune Diseases Treated with Adalimumab.
Free. We’ll email you when a new paper cites this one or any other paper you follow on JClub — at most one email a day. Every email has a one-tap unsubscribe.